CD163 Expression Was Associated with Angiogenesis and Shortened Survival in Patients with Uniformly Treated Classical Hodgkin Lymphoma

Prognostic role of tumor-associated macrophages and angiogenesis in classical Hodgkin lymphoma

(2013) Luigi Panico et al.   LEUKEMIA & LYMPHOMA

Tumor associated macrophages in relapsed and refractory Hodgkin lymphoma

(2013) Carla Casulo et al.   LEUKEMIA RESEARCH

Impact of the Epstein–Barr virus positivity on Hodgkin's lymphoma in a large cohort from a single institute in Korea

(2012) Young Wha Koh et al.   ANNALS OF HEMATOLOGY

A phase 2 trial of standard-dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: SWOG 0515

(2012) A. T. Stopeck et al.   BLOOD

Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial

(2012) K. L. Tan et al.   BLOOD

CD163 versus CD68 in tumor associated macrophages of classical hodgkin lymphoma

(2012) Jonathan A Harris et al.   Diagnostic Pathology

Immunohistochemical markers for tumor associated macrophages and survival in advanced classical Hodgkin's lymphoma

(2012) B. Sanchez-Espiridion et al.   HAEMATOLOGICA

Tumor associated macrophages and neutrophils in tumor progression

(2012) Maria R. Galdiero et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Expression of FOXP3, CD68, and CD20 at Diagnosis in the Microenvironment of Classical Hodgkin Lymphoma Is Predictive of Outcome

(2012) Paul Greaves et al.   JOURNAL OF CLINICAL ONCOLOGY

Tumor-associated macrophages promote angiogenesis and lymphangiogenesis of gastric cancer

(2012) Hui Wu et al.   JOURNAL OF SURGICAL ONCOLOGY

The Ratio of the Absolute Lymphocyte Count to the Absolute Monocyte Count Is Associated with Prognosis in Hodgkin's Lymphoma: Correlation with Tumor-Associated Macrophages

(2012) Y. W. Koh et al.   ONCOLOGIST

Prognostic Significance of Bcl-2, Tumor-Associated Macrophages, and Total Neoplastic and Inflammatory Lymph Node Involvement in Advanced Stage Classical Hodgkin’s Lymphoma

(2012) Ljubomir R. Jakovic et al.   ONKOLOGIE

Tumor-associated macrophages and angiogenesis: A statistical correlation that could reflect a critical relationship in ameloblastoma

(2012) Rebeca Guzmán-Medrano et al.   PATHOLOGY RESEARCH AND PRACTICE

Clinical features and outcomes of Hodgkin’s lymphoma in Korea: Consortium for Improving Survival of Lymphoma (CISL)

(2011) Young-Woong Won et al.   ANNALS OF HEMATOLOGY

Specifically Targeting Angiopoietin-2 Inhibits Angiogenesis, Tie2-Expressing Monocyte Infiltration, and Tumor Growth

(2011) H. Huang et al.   CLINICAL CANCER RESEARCH

CD68 and CD163 as prognostic factors for Korean patients with Hodgkin lymphoma

(2011) Dok Hyun Yoon et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphoma

(2011) L. F. Porrata et al.   HAEMATOLOGICA

The prognostic relevance of tumor associated macrophages in advanced stage classical Hodgkin lymphoma

(2011) Ljubomir R. Jakovic et al.   LEUKEMIA & LYMPHOMA

Cardiac toxicity associated with bevacizumab (Avastin) in combination with CHOP chemotherapy for peripheral T cell lymphoma in ECOG 2404 trial

(2011) Ranjana H. Advani et al.   LEUKEMIA & LYMPHOMA

The Tissue Microlocalisation and Cellular Expression of CD163, VEGF, HLA-DR, iNOS, and MRP 8/14 Is Correlated to Clinical Outcome in NSCLC

(2011) Chandra M. Ohri et al.   PLoS One

CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans

(2011) G. L. Beatty et al.   SCIENCE

Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma

(2011) Mona A. A. Zaki et al.   VIRCHOWS ARCHIV

Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction

(2010) A. Fantin et al.   BLOOD

Salvage Therapy for Hodgkin’s Lymphoma

(2010) Fahd Quddus et al.   CANCER JOURNAL

Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma

(2010) P. Kamper et al.   HAEMATOLOGICA

Bridges that guide and unite

(2010) Thomas Schmidt et al.   NATURE

Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma

(2010) Christian Steidl et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tumor-Associated Macrophage Correlated with Angiogenesis and Progression of Mucoepidermoid Carcinoma of Salivary Glands

(2009) Yi-Shing Shieh et al.   ANNALS OF SURGICAL ONCOLOGY

Identification of a Subpopulation of Macrophages in Mammary Tumor-Bearing Mice That Are Neither M1 nor M2 and Are Less Differentiated

(2009) M. Torroella-Kouri et al.   CANCER RESEARCH

Rapid release of cytoplasmic IL-15 from tumor-associated macrophages is an initial and critical event in IL-12-initiated tumor regression

(2009) Stephanie K. Watkins et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Interferon-γ reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages

(2009) Dorothée Duluc et al.   INTERNATIONAL JOURNAL OF CANCER

Effects of the Anti-VEGF Monoclonal Antibody Bevacizumab in a Preclinical Model and in Patients With Refractory and Multiple Relapsed Hodgkin Lymphoma

(2009) Katrin S. Reiners et al.   JOURNAL OF IMMUNOTHERAPY

Angiogenesis and antiangiogenic therapy in non-Hodgkin's lymphoma

(2008) J. Ruan et al.   ANNALS OF ONCOLOGY

Histological expression of angiogenic factors: VEGF, PDGFRα, and HIF-1α in Hodgkin lymphoma

(2008) Freda H. Passam et al.   PATHOLOGY RESEARCH AND PRACTICE